| Product Code: ETC8194639 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Despite a decline in growth rate in 2024, Malta continues to import insulin biosimilars mainly from the UK, Germany, Italy, Netherlands, and Spain. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market with dominant exporters. With a modest compound annual growth rate (CAGR) of 2.77% from 2020 to 2024, Malta demand for these products remains steady. The negative growth rate in 2024 could be a temporary anomaly, and it will be interesting to monitor how the market dynamics evolve in the coming years.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malta Insulin Biosimilars Market Overview |
3.1 Malta Country Macro Economic Indicators |
3.2 Malta Insulin Biosimilars Market Revenues & Volume, 2021 & 2031F |
3.3 Malta Insulin Biosimilars Market - Industry Life Cycle |
3.4 Malta Insulin Biosimilars Market - Porter's Five Forces |
3.5 Malta Insulin Biosimilars Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Malta Insulin Biosimilars Market Revenues & Volume Share, By Indicative, 2021 & 2031F |
3.7 Malta Insulin Biosimilars Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Malta Insulin Biosimilars Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Malta Insulin Biosimilars Market Trends |
6 Malta Insulin Biosimilars Market, By Types |
6.1 Malta Insulin Biosimilars Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Malta Insulin Biosimilars Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Malta Insulin Biosimilars Market Revenues & Volume, By Rapid-acting biosimilar, 2021- 2031F |
6.1.4 Malta Insulin Biosimilars Market Revenues & Volume, By Long-acting biosimilar, 2021- 2031F |
6.1.5 Malta Insulin Biosimilars Market Revenues & Volume, By Premixed biosimilar, 2021- 2031F |
6.2 Malta Insulin Biosimilars Market, By Indicative |
6.2.1 Overview and Analysis |
6.2.2 Malta Insulin Biosimilars Market Revenues & Volume, By Type I Diabetes, 2021- 2031F |
6.2.3 Malta Insulin Biosimilars Market Revenues & Volume, By Type II Diabetes, 2021- 2031F |
6.3 Malta Insulin Biosimilars Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Malta Insulin Biosimilars Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Malta Insulin Biosimilars Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.4 Malta Insulin Biosimilars Market Revenues & Volume, By Others, 2021- 2031F |
7 Malta Insulin Biosimilars Market Import-Export Trade Statistics |
7.1 Malta Insulin Biosimilars Market Export to Major Countries |
7.2 Malta Insulin Biosimilars Market Imports from Major Countries |
8 Malta Insulin Biosimilars Market Key Performance Indicators |
9 Malta Insulin Biosimilars Market - Opportunity Assessment |
9.1 Malta Insulin Biosimilars Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Malta Insulin Biosimilars Market Opportunity Assessment, By Indicative, 2021 & 2031F |
9.3 Malta Insulin Biosimilars Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Malta Insulin Biosimilars Market - Competitive Landscape |
10.1 Malta Insulin Biosimilars Market Revenue Share, By Companies, 2024 |
10.2 Malta Insulin Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here